Efficacy of fipronil combined with permethrin commercial spot on (Effitix®) preventing  from feeding on dogs by unknown
ORIGINAL PAPER
Efficacy of fipronil combined with permethrin commercial spot
on (Effitix®) preventing Culex pipiens from feeding on dogs
Michel Franc & Emmanuel Lienard & Philippe Jacquiet &
Stephane Bonneau & Emilie Bouhsira
Received: 18 February 2015 /Accepted: 23 February 2015 /Published online: 5 March 2015
# The Author(s) 2015. This article is published with open access at Springerlink.com
Abstract A controlled clinical trial was carried out to assess
the adulticidal and anti-feeding effectiveness of a spot-on
combining fipronil and permethrin (Effitix®, Virbac, Carros,
France) in preventing Culex pipiens from feeding on dogs.
Twelve dogs with equal sensitivity to mosquitoes were includ-
ed in the study and divided into two groups of six dogs: an
untreated control group and a group treated with Effitix®. All
dogs were challenged with 80 females C. pipiens for 90±
5 min on days −7, 1, 7, 14, 21, and 28 (day 0 being treatment
day). The number of engorged, dead, and live mosquitoes was
determined after each exposure to treated and untreated dogs.
Dead mosquitoes were also counted 24 h after exposure. The
anti-feeding effect of the spot-on formulation was 100, 99.5,
97.7, 98.3, and 96.7 % on days 1, 7, 14, 21, and 28, respec-
tively. The mortality effect was 66.6, 55.9, 38, 17.2, and
12.3 % on days 1, 7, 14, 21, and 28, respectively. At each
challenge point, the mortality and anti-feeding effects on mos-
quitoes were significantly different between the control and
treated group (p<0.05). The results indicate that a combina-
tion of permethrin and fipronil could be used as an effective
mosquito control strategy in dogs and is therefore recom-
mended for use in a dirofilariasis prevention program.
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Introduction
The two species of mosquitoes, Culex pipiens and Aedes
albopictus, are important vectors of Dirofilaria immitis and
Dirofilaria repens worldwide (Licitra et al. 2010; McKay et al.
2013). D. immitis, the agent of heartworm disease, causes severe
disorders and even death in dogs in many parts of the world
(McCall et al. 2008). The prevalence of both dirofilariasis is very
high in the USA (Carleton and Tolbert 2004; Bowman et al.
2007; McKay et al. 2013), in Central America (Bolio-Gonzalez
et al. 2007; Caro-Gonzalez et al. 2011), Asia (Oi et al. 2014),
Russia (Ermakova et al. 2014), and in some European countries
(Genchi et al. 2011). Endemic areas are present in the south of
France, in Italy (Capelli et al. 2013; Giangaspero et al. 2013),
Spain (Montoya-Alonso et al. 2010), Portugal (Santa-Ana et al.
2006), Germany (Sassnau et al. 2014), Poland (Demiaszkiewicz
et al. 2014), Hungary (Farkas et al. 2014; Tolnai et al. 2014), and
in Romania (Mircean et al. 2012). In addition, the filarial nema-
todes, D. immitis and D. repens, are zoonotic agents (Theis,
2005). In humans, ocular, subcutaneous, and pulmonary forms
have been reported (McCall et al. 2008; Kalogeropoulos et al.
2014; Otranto et al 2011a, 2011b).
An integrated control program against dirofilariasis may be
implemented by the association of macrocyclic lactones and the
application of insecticides with an antifeeding effect on mosqui-
toes (Hellmann et al. 2011, Snyder et al. 2011; Genchi et al.
2013; Traversa et al. 2013; Di Cesare et al. 2014). Pyrethroids
such as permethrin and deltamethrin are known to be effective
against sandflies and mosquitoes and are widely used in com-
panion animals (Beugnet and Franc 2012). Other molecules such
as fipronil, metaflumizone, and pyriprole are effective against
fleas and tick, but could not be used to prevent mosquitoes from
biting dogs (Bouhsira et al. 2009).
The aimof the studywas to evaluate the adulticidal (ormortality)
and repellent effects of a spot-on containing fipronil and permethrin
(Effitix®, Virbac, Carros, France) on C. pipiens in dogs.
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Materials and methods
The study was conducted in the National Veterinary School of
Toulouse (ENVT) and was a single-center, randomized,
blinded, controlled efficacy study on two groups of seven
dogs each. Dogs were handled in accordance with the Animal
Welfare and Good Clinical Practice, and the study protocol
was approved by the Ethics Committee of Midi-Pyrenees. All
personnel involved in the collection of efficacy data were
blinded to the treatment.
Dogs
Five male and seven female Beagle dogs (3 years of age and
weighing between 8.02 and 10.94 kg) were included in the
study. They had not been exposed to ectoparasiticides for
3 months prior to the inclusion and remained in good health
throughout the study. They were housed in cages individually
and had a 4-h daily access to a 2×4 m concrete run without
contact with another dog. To avoid cross-contamination, treated
and untreated dogs were placed in two different exercise areas.
Each dog was identified with the number of a subcutaneously
implanted microchip. They were fed a commercial dry dog
food with a ration that maintained the animal in a healthy phys-
ical state. Water was available ad libitum through automatic
lickers. Dogs were maintained and handled with due regard
for their welfare and were acclimatized to the caged environ-
ment for 17 days prior to treatment. They were observed daily
for their general health conditions throughout the trial. No con-
current medication was needed to be given during the study.
On day −7, each dog was challenged with 80 unfed adult
females of C. pipiens. The number of engorged female mos-
quitoes was used for ranking and group allocation. Dogs were
ranked in descending order according to their individual pre-
treatment mosquito’s engorgement status. They were then in-
troduced into blocks of two animals each, and within each
block, dogs were randomly allocated into two groups: treat-
ment or control group.
Mosquito maintenance and supply
The C. pipiens exposure was performed using laboratory-
reared adults (females only). This mosquito strain was obtain-
ed from the Interdepartmental Agreement for Mosquito Con-
trol (EID) and was maintained at ENVT under laboratory con-
ditions since 2001 using a 3-week egg to adult.
Treatment
The six dogs from the control group (group A)
remained untreated, and the six dogs from the treated
group (group B) received on day 0 a spot-on combina-
tion of permethrin and fipronil: one pipette of 1.1 ml
(593.4 mg of permethrin and 67.7 mg of fipronil) for
dogs weighing between 4.1 and 10.0 kg and one pipette
of 2.2 ml (137.2 mg of fipronil and 1197.8 mg of per-
methrin) for dogs weighing between 10.1 and 20 kg.
Treatment dosages were within the range of 67.7–
137.2 mg kg−1 for permethrin and 7–13.5 mg kg−1 for
fipronil. For all treated animals, the formulation was
applied according to the manufacturer’s instructions by
parting the hair and applying the formulation directly
onto the skin in two areas: between the shoulder blades
and the lumbar area. All dogs were observed at 2 and
4 h after treatment for any adverse reaction to the
product.
Experimental procedure
The 12 dogswere infested with 80 (±2)C. pipiens for a total of
six times. Two days before exposure, mosquitoes were aspi-
rated from their breeding cage with a vacuum pump and then
placed in challenge nets (80±2 females per net) with access to
water-soaked cotton and honey. The mosquito challenge as-
sessment cages (60 cm×40 cm×50 cm) were constructed
from mosquito netting mounted on a wooden frame and
placed in environmentally controlled rooms. Mosquitoes were
fasted 24 h prior to exposure to dogs by removing honey from
the cages.
Before exposure, dogs were sedated by intramuscular in-
jection of medetomidine (Dexdomitor®, Pfizer Santé animale,
Paris, France), ketamine (Clorketam®, Laboratoire
Vetoquinol S.A., Lure, France), and diazepam(Valium®,
Roche injectable, Neuilly s/ Seine, France) at a dose rate of
4 μg/kg, 9 mg/kg, and 5mg/dog, respectively, and then placed
in individual infestation proof nets containing mosquitoes.
The dosage of the anesthetic was calculated so as to immobi-
lize dogs for 90 min. During infestation, treated dogs and
control dogs were placed in separated infestation rooms where
temperature and relative humidity were maintained between
25 and 26 °C and between 58 and 72 %, respectively. Cages
and nets were thoroughly cleaned after each mosquito
challenge.
After 90±5 min of exposure, the dogs were carefully
taken out of the net and examined for any dead mosquito
on their body and then placed back in their cage. All live
mosquitoes were aspirated from each challenge net using
a vacuum pump and were categorized as live engorged
or non-engorged. All dead mosquitoes were collected,
counted, and categorized as dead non-engorged or dead
engorged. On days −7, 1, 7, 14, 21, and 28, live mos-
quitoes recovered from individual animals at the end of
exposure were placed in separate nets and kept in the
experimental room. The mosquitoes were fed on sugar–
water and checked for mortality after 24 h. Then, all
remaining mosquitoes were discarded.
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Data analysis
Antifeeding effect
For each time point after exposure, the antifeeding effect was
calculated as described by:
Antifeedingeffect ¼ 100*Ce−Te
Ce
where Ce was the arithmetic mean of engorged female
mosquitoes (live engorged and dead engorged) for the control
group and Te was the arithmetic mean of the engorged female
mosquitoes for the treated group.
Mortality effect
For each time point after exposure, the mortality effect was
evaluated for each group as described by:
Mortalityeffect ¼ 100*Cl −Tl
Cl
where Cl was the arithmetic mean of live female mosquitoes
(live engorged and live unengorged) for the control group and Tl
was the arithmeticmeanof the live femalemosquitoes for the treated
group.
Themortality effect was calculated at 90min and 24 h post-
exposure.
Statistical analysis
Both groups were compared for the number of engorged fe-
males and the number of dead females at each challenge point
using the non-parametric test of Kruskal–Wallis. The analyses
were performed with Systat 9 software; differences were con-
sidered significant at p<0.05.
Results
No adverse events relative to treatment were reported.
Antifeeding effect on mosquitoes
The 12 dogs included in the study demonstrated adequate pre-
treatment parasite-holding ability (i.e., over 50 % of engorged
females per dog; Fig. 1). On day −7, the percentage of engorged
females was 78.1 and 76.6 % for the treated and control group,
respectively. All control dogs maintained an adequate number
of engorged females (i.e., between 76.6 and 83.7%) throughout
the study (Fig. 1). The treatment had an anti-feeding effect
between 100 and 99.5 % during the first 2 weeks and between
98.3 and 96.7 % until the end of the trial (Table 1).
At each challenge point post-treatment, the difference in
engorgement status of C. pipiens females between treated
and controlled group was significant (p<0.05).
Mortality effect on mosquitoes
The mortality effects of the treatment calculated at 1 and 24 h
post-exposure to treated dogs are reported in Table 1. The
mortality effect observed at 1 h ranged from 66.6 to 55.9 %






























Fig. 1 Mean number of engorged
Culex pipiens females after 1 h
exposure to control and treated
dogs. Dogs were treated on day 0
with a permethrin and fipronil
combination spot-on and then
weekly challenged with 80 Culex
pipiens females
Table 1 Mortality and antifeeding effect of a permethrin and fipronil











Mortality effect (%) 1.5 h 66.6 55.9 38 17.2 12.3
24 h 69.1 58.1 38 17.8 15.1
Anti-feeding effect
(%)
1 h 100 99.5 97.7 98.3 96.7
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ranging from 38 to 12.3 % until the end of the study. The
mortality effect of the formulation has not increased within
the 24 h post-exposure and was close to the one obtained at
1 h. At each challenge point, there was a significant difference
(p<0.05) in the number of dead mosquitoes found at 1 and
24 h of exposure between the treated and control group.
Discussion
The aim of the study was to determine the antifeeding (or
repellency) and mortality (or insecticidal) efficacies of a new
formulation combining fipronil and permethrin (Effitix®,
Virbac, Carros, France) against a European strain ofC. pipiens
in dogs. The formulation was administered according to the
manufacturer’s recommendations and the dogs received, ac-
cording to their weight, between 67.7 and 137.2 mg.kg−1of
permethrin and between 7 and 13.5 mg.kg−1of fipronil. In
these conditions, the treatment provided an immediate effica-
cy of 100 % at 24 h after the administration. Then, the formu-
lation provided an excellent inhibition of feeding which
remained above 96.7 % for the 4 weeks of the study.
The repellency of fipronil combined with permethrin ob-
tained in our study was higher than the repellency obtained
with the same association against an American strain of
C. pipiens (Fankhauser et al. 2015). In this study, the authors
obtained a repellency rate of 99.4, 98.9, 94.7, 91.7, and 90.4%
on days 1, 7, 14, 21, and 28, respectively. This could be ex-
plained by the fact that dogs were treated at the minimal dose
of the product, i.e., 50.48 mg kg−1 of permethrin and
6.76 mg kg−1 of fipronil versus 67.7 mg kg−1 of permethrin
and 7 mg kg−1 of fipronil in our study. A previous study had
been carried out in the same laboratory as the current study to
assess the repellency and the insecticidal efficacy of fipronil
combinedwith (S) methoprene on the same European strain of
C. pipiens (Bouhsira et al. 2009). The repellency rate was
40.2 % on day 1 and 45.8 % on day 7 respectively while the
insecticidal efficacy was 32.3 and 51.8 % on the same days.
This combination had a reduced activity on C. pipiens which
could not be considered as efficient enough to protect dogs
against this mosquito. Therefore, the excellent inhibition of
feeding provided by Effitix® is mainly due to permethrin.
The product demonstrated mortality or insecticidal efficacy
close to 60 % the first week after treatment which then de-
creased on days 14, 21, and 28. Fankhauser et al. (2015)
obtained an insecticidal efficacy between 92.1 and 26.9 %.
This lower insecticidal efficacy was explained by the strong
repellent effect on C. pipiens, which could prevent them from
landing on the treated animals and therefore limiting contact
with the insecticide molecules (Fankhauser et al. 2015).
In conclusion, the new fipronil and permethrin
ectoparasiticide combination offers a protection against
C. pipiens in dogs for 1 month following a single
topical application. This treatment could contribute to
the reduction of stress and annoyance caused by the bite
of mosquitoes, and more importantly, it may reduce the
risk of heartworm transmission in animals living in or
travelling to dirofilariasis endemic areas. However, it
should not be seen as a substitute for heartworm pre-
vention treatment but should be part of an integrated
prevention program.
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